• Thurs news: Merck - Weight-loss drugs and healthcare costs. GSK and Pfizer RSV vaccines in younger adults. Pharma mega-mergers. Lilly launches Mounjaro in Denmark. Lundbeck pipeline. See more on our front page

Blockbuster drugs to save the company

Anonymous

Guest
LOL!!!!!!!!Just like there isn't a novel thought in Doug's,head,there are no novel drugs that will save this company! Just a bunch of retreads,like our management team!
 




Blockbuster products WILL save the company. Ufortunately the company is Pfizer, Merck or GSK. Takeda has nothing resembling a billion dollar product in the pipeline until around 2018. We will draw down to 500-800-reps by then.
 




Blockbuster products WILL save the company. Ufortunately the company is Pfizer, Merck or GSK. Takeda has nothing resembling a billion dollar product in the pipeline until around 2018. We will draw down to 500-800-reps by then.

Idiot. They won't keep 500-800 reps for small $$. Everyone is gone after Actos. Ventiv and Publicis will handle the mop up.
 








Idiot. They won't keep 500-800 reps for small $$. Everyone is gone after Actos. Ventiv and Publicis will handle the mop up.

The talent level at Ventiv and Publicis is actually higher than what is left at Takeda. Top quality people from Merck, Pfizer, and Amgen will probably actually go out and SELL something. This will be the best move for Takeda...but the worst move for shitty reps.